Argentina - Re-Import of Heparin for Therapeutic Use

Since 2014, Argentina Re-Import of Heparin for Therapeutic Use fell by 13.7% year on year. In 2019, the country was ranked number 5 comparing other countries in Re-Import of Heparin for Therapeutic Use at $282,142.75. Argentina is overtaken by France, which was ranked number 4 with $378,030.03 and is followed by New Zealand with $40,139.76. Canada lead the ranking with $1,738,281.5 in 2019, that is a growth of 72.9% versus 2018. Australia recorded the best 5 years average growth at +309.1% per year, while Thailand recorded the worst performance at -47.1% per year.

Loading...

Date US Dollars
2019 282,142.75
2018 133,947.89
2017 545,814.75
2016 682,022.31
2015 269.00
Download all data from 2009 to 2019

How does Argentina rank in Re-Import of Heparin for Therapeutic Use?

# 9 Countries US Dollars Last YoY 5‑years CAGR
1 #1
Canada
1,738,281.50 2019 +72.9 % +112.5 % View data
2 #2
Australia
1,253,862.50 2019 +10.8 % +309.1 % View data
4 #4
France
378,030.03 2019 -14.2 % -8.6 % View data
5 #5
Argentina
282,142.75 2019 +110.6 % -13.7 % View data
6 #6
New Zealand
40,139.76 2019 +27.3 % +60.2 % View data
Compare all 9 countries

Go Top